These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 9030403)

  • 1. Functional changes induced by neonatal cerebral 6-hydroxydopamine treatment: effects of dose levels on behavioral parameters.
    Luthman J; Bassen M; Fredriksson A; Archer T
    Behav Brain Res; 1997 Jan; 82(2):213-21. PubMed ID: 9030403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neonatal 6-hydroxydopamine-induced dopamine depletions: motor activity and performance in maze learning.
    Archer T; Danysz W; Fredriksson A; Jonsson G; Luthman J; Sundström E; Teiling A
    Pharmacol Biochem Behav; 1988 Oct; 31(2):357-64. PubMed ID: 3149743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnitude and duration of hyperactivity following neonatal 6-hydroxydopamine is related to the extent of brain dopamine depletion.
    Miller FE; Heffner TG; Kotake C; Seiden LS
    Brain Res; 1981 Dec; 229(1):123-32. PubMed ID: 6796194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neonatal 6-hydroxydopamine lesions of the frontal cortex in rats: persisting effects on locomotor activity, learning and nicotine self-administration.
    Rezvani AH; Eddins D; Slade S; Hampton DS; Christopher NC; Petro A; Horton K; Johnson M; Levin ED
    Neuroscience; 2008 Jun; 154(3):885-97. PubMed ID: 18511204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional changes implicating dopaminergic systems following perinatal treatments.
    Archer T; Fredriksson A
    Dev Pharmacol Ther; 1992; 18(3-4):201-22. PubMed ID: 1306809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Spontaneous motor activity and radial-maze learning in rats neonatally treated with 6-hydroxydopamine].
    Iwasaki T; Takasuna M
    Yakubutsu Seishin Kodo; 1986 Dec; 6(4):381-8. PubMed ID: 3103348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperactivity in neonatally dopamine-lesioned rats requires residual activity in mesolimbic dopamine neurons.
    Luthman J; Lindqvist E; Ogren SO
    Pharmacol Biochem Behav; 1995 May; 51(1):159-63. PubMed ID: 7617728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neonatal brain dopamine depletion and the cortical and behavioral consequences of enriched postweaning environment.
    Pappas BA; Murtha SJ; Park GA; Condon KT; Szirtes RM; Laventure SI; Ally A
    Pharmacol Biochem Behav; 1992 Aug; 42(4):741-8. PubMed ID: 1513856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behavioural retardation in the neuropathology of mental retardation.
    Archer T
    APMIS Suppl; 1993; 40():35-56. PubMed ID: 7906129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behavioural supersensitivity following neonatal 6-hydroxydopamine: attenuation by MK-801.
    Archer T; Fredriksson A
    Neurotox Res; 2007 Sep; 12(2):113-24. PubMed ID: 17967735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Possible involvement of serotonergic neurons in the reduction of locomotor hyperactivity caused by amphetamine in neonatal rats depleted of brain dopamine.
    Heffner TG; Seiden LS
    Brain Res; 1982 Jul; 244(1):81-90. PubMed ID: 6288184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of methamphetamine on the locomotor activity in the 6-OHDA dorsal hippocampus lesioned rat.
    Itoh K; Fukumori R; Suzuki Y
    Life Sci; 1984 Feb; 34(9):827-33. PubMed ID: 6422178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variability among brain regions in the specificity of 6-hydroxydopamine (6-OHDA)-induced lesions.
    Commins DL; Shaughnessy RA; Axt KJ; Vosmer G; Seiden LS
    J Neural Transm; 1989; 77(2-3):197-210. PubMed ID: 2503586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
    Breese GR; Duncan GE; Napier TC; Bondy SC; Iorio LC; Mueller RA
    J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Active and passive avoidance learning in rats neonatally treated with intraventricular 6-hydroxydopamine.
    Takasuna M; Iwasaki T
    Behav Brain Res; 1996 Jan; 74(1-2):119-26. PubMed ID: 8851920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Desipramine attenuates working memory impairments induced by partial loss of catecholamines in the rat medial prefrontal cortex.
    Clinton SM; Sucharski IL; Finlay JM
    Psychopharmacology (Berl); 2006 Jan; 183(4):404-12. PubMed ID: 16307295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neonatal 6-OHDA lesions differentially affect striatal D1 and D2 receptors.
    Neal BS; Joyce JN
    Synapse; 1992 May; 11(1):35-46. PubMed ID: 1351321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Latent learning in a radial arm maze following neonatal dopamine depletion.
    Archer T; Beninger RJ; Järbe TU; Seiden LS
    Behav Pharmacol; 1989; 1(3):191-199. PubMed ID: 11224030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of neurotensin microinjected into ventral tegmental area on spontaneous motor activity in neonatal 6-hydroxydopamine-treated rats].
    Ikegami M; Iwasaki T
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2004 Apr; 24(2):83-5. PubMed ID: 15164616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional alteration by NMDA antagonist: effects of L-Dopa, neuroleptics drug and postnatal administration.
    Fredriksson A; Archer T
    Amino Acids; 2002; 23(1-3):111-32. PubMed ID: 12373526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.